Similar articles

• A comparison of aralkylamines and aralkylguanidines as antagonists of adrenergic neurone blockade.

  Fielden R, Green AL. Fielden R, et al. J Pharm Pharmacol. 1966 Nov;18(11):721-8. doi: 10.1111/j.2042-7158.1966.tb07793.x. J Pharm Pharmacol. 1966. PMID: 4382048 No abstract available.
• A comparative study of the noradrenaline-depleting and sympathetic-blocking actions of guanethidine and (-)-beta-hydroxyphenethylguanidine.

  Fielden R, Green AL. Fielden R, et al. Br J Pharmacol Chemother. 1967 May;30(1):155-65. doi: 10.1111/j.1476-5381.1967.tb02121.x. Br J Pharmacol Chemother. 1967. PMID: 6039969 Free PMC article. No abstract available.
• New norepinephrine-depleting agents. Beta-hydroxyphenethylguanidine and related compounds.

  Green AL, Fielden R, Bartlett DC, Cozens MJ, Eden RJ, Hills DW. Green AL, et al. J Med Chem. 1967 Nov;10(6):1006-8. doi: 10.1021/jm00318a004. J Med Chem. 1967. PMID: 6056024 No abstract available.
• The chemistry of guanidines and their actions at adrenergic nerve endings.

  Durant GJ, Roe AM, Green AL. Durant GJ, et al. Prog Med Chem. 1970;7(1):124-213. doi: 10.1016/s0079-6468(08)70353-9. Prog Med Chem. 1970. PMID: 4992683 Review. No abstract available.
• The influence of age on the activity of catecholamines and related therapeutic agents.

  Bender AD. Bender AD. J Am Geriatr Soc. 1970 Mar;18(3):220-32. doi: 10.1111/j.1532-5415.1970.tb02123.x. J Am Geriatr Soc. 1970. PMID: 4907254 Review. No abstract available.